ProStrakan Limited - search results

stexerol-d3 1,000 iu film-coated tablets

prostrakan limited - colecalciferol - film-coated tablets - 1,000 iu - vitamin supplements - stexerol-d3 is indicated in adults, the elderly and adolescents for prevention and treatment of vitamin d deficiency. as an adjunct to specific therapy for osteoporosis in patients with vitamin d deficiency or at risk of vitamin d insufficiency.

United Kingdom - English - myHealthbox

stexerol-d3 25,000 iu film-coated tablets

prostrakan limited - colecalciferol - film-coated tablets - 25,000 iu - vitamin supplements - stexerol-d3 is indicated in adults, the elderly and adolescents for prevention and treatment of vitamin d deficiency. as an adjunct to specific therapy for osteoporosis in patients with vitamin d deficiency or at risk of vitamin d insufficiency.

Ireland - English - HPRA (Health Products Regulatory Authority)

abstral tablet sublingual 50 microgram

prostrakan limited - fentanyl - tablet sublingual - 50 microgram

Ireland - English - HPRA (Health Products Regulatory Authority)

abstral 50 microgram tablet sublingual

prostrakan limited - fentanyl - tablet sublingual - 50 microgram

United States - English - NLM (National Library of Medicine)

abstral- fentanyl tablet

prostrakan, inc. - fentanyl citrate (unii: mun5lyg46h) (fentanyl - unii:uf599785jz) - fentanyl 100 ug - abstral (fentanyl) sublingual tablets are indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. patients considered opioid tolerant are those who are taking around-the-clock medicine consisting of at least 60 mg of oral morphine daily, or at least 25 mcg of transdermal fentanyl/hour, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily or at least 25 mg oral oxymorphone daily, or an equianalgesic dose of another opioid medication daily for a week or longer. patients must remain on around-the-clock opioids when taking abstral. abstral is contraindicated for patients who are not already tolerant to opioids because life-threatening respiratory depression and death could result at any dose in patients not on a chronic regimen of opioids. for this reason, abstral is contraindicated in the management of acute or postoperative pain,